^
    Back
    Association details:
    Biomarker:TUSC7 overexpression
    Cancer:Triple Negative Breast Cancer
    Drug:carboplatin (Tubulin polymerization promoter)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    New
    Source:
    Cancer Manag Res
    Title:

    The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer

    Published date:
    07/17/2021
    Excerpt:
    TUSC7 overexpression significantly promoted the sensitivity of MDA-MB-468 cells to paclitaxel and carboplatin.
    DOI:
    10.2147/CMAR.S305865